We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Compliance With Once Daily Glaucoma Medication

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00333463
First Posted: June 5, 2006
Last Update Posted: November 18, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Johns Hopkins University
University of Pennsylvania
Information provided by (Responsible Party):
Alcon Research
  Purpose
A study to examine patient compliance with once daily glaucoma medication

Condition Intervention
Compliance Behavioral: Intervention

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Compliance With Once Daily Glaucoma Medication

Resource links provided by NLM:


Further study details as provided by Alcon Research:

Estimated Enrollment: 700
Study Start Date: June 2006
Study Completion Date: September 2007
Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Intervention group
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
Behavioral: Intervention
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
Non-Intervention Group
The control group was told to take drops as prescribed and received no additional intervention.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Primary open angle glaucoma or ocular hypertension patients
Criteria

Inclusion Criteria:

  • Primary open angle glaucoma or ocular hypertension patients

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00333463


Locations
United States, Texas
Ft. Worth
Ft. Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research
Johns Hopkins University
University of Pennsylvania
Investigators
Study Director: David Friedman, MD Study Director
  More Information

Publications:
Responsible Party: Alcon Research
ClinicalTrials.gov Identifier: NCT00333463     History of Changes
Other Study ID Numbers: CMS-06-03
First Submitted: June 1, 2006
First Posted: June 5, 2006
Last Update Posted: November 18, 2016
Last Verified: March 2010

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases